Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

First in Man Trial - BIOSOLVE-I

This study has been completed.
Information provided by (Responsible Party):
Biotronik AG Identifier:
First received: July 22, 2010
Last updated: February 4, 2015
Last verified: February 2015